IP Library Granted Patent US 9,358,251
Granted Patent B2
US 9,358,251 · App. 12/516,001 · Granted Jun 7, 2016

Dissolution and processing of cellulose

Inventors: David Kershaw (Deeside, GB); Simon Adams (Deeside, GB)
Assignee: CONVATEC TECHNOLOGIES INC.
A61K31/717A61L15/28C08B11/12C08B11/20C08B11/22C08J3/096C08L1/286C08J2301/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,358,251
App. No.
12/516,001
Granted
Jun 7, 2016
Kind
B2
Abstract

The invention relates to a method for dissolving the components of gel forming materials suitable for use in wound care comprising the steps of admixing said components with an ionic liquid. The ionic liquid may be selected from the group of tertiary amine N-oxides, N,N-dimethyl formamide/nitrogen tetroxide mixtures, dimethyl sulphoxide/paraformaldehyde mixtures and solutions of limium chloride in N,N-dimethyl acetamide or N-methyl pyrrolidone.

Claims (19)

1. A method for dissolving the components of gel forming materials suitable for use in wound care wherein the components comprise carboxymethylcellulose, the method consisting essentially of the steps of admixing said components with an ionic liquid consisting essentially of a liquid ionic compound which is liquid below 150° C., the liquid ionic compound having:

(i) a cation with a structure selected from:

2. The method as claimed in claim 1 , wherein the carboxymethylcellulose is a carboxymethylcellulose powder.

3. A method for regeneration of chemically modified cellulose that comprises preparing a solution of chemically modified cellulose, wherein the chemically modified cellulose is a carboxymethylcellulose, in an ionic liquid by dissolving the chemically modified cellulose in said ionic liquid; and admixing the solution with a liquid non-solvent for the chemically modified cellulose that is miscible with said ionic liquid, said admixing causes the cellulose and ionic liquid to form solid and liquid phases, wherein the ionic liquid consists essentially of a liquid ionic compound which is liquid below 150° C. and the properties of the dissolved or regenerated carboxymethylcellulose are similar to the properties of the carboxymethylcellulose prior to dissolution, the liquid ionic compound having:

(i) a cation with a structure selected from:

wherein

R 1 and R 2 are independently C 1 -C 6 alkyl or C 1 -C 6 alkoxyalkyl; and

R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are independently H, C 1 -C 6 alkyl, C 1 -C 6 alkoxyalkyl, or C 1 -C 6 alkoxy; and

(ii) an anion selected from halogen, pseudohalogen, or C 1 -C 6 carboxylate.

4. The method as claimed in claim 3 , wherein the carboxymethylcellulose is a carboxymethylcellulose powder.

5. The method as claimed in claim 1 , wherein the carboxymethylcellulose is processed into a fiber, a nanofiber, a film, a coating, a foam or a sponge.

6. The method as claimed in claim 1 , wherein the carboxymethylcellulose is processed into a fiber.

7. The method as claimed in claim 6 , wherein the carboxymethylcellulose fiber is sodium carboxymethyl cellulose fiber.

8. The method as claimed in claim 7 , wherein the sodium carboxymethyl cellulose fibre has a degree of substitution of at least 0.05 carboxymethyl groups per glucose unit and a tenacity of at least 10 cN/tex.

9. The method as claimed in claim 1 , wherein the carboxymethylcellulose is suitable for use in the treatment of wounds.

10. The method as claimed in claim 3 , wherein the carboxymethylcellulose is processed into a fiber, a nanofiber, a film, a coating, a foam or a sponge.

11. The method as claimed in claim 3 , wherein the carboxymethylcellulose is processed into a fiber.

12. The method as claimed in claim 11 , wherein the carboxymethyl cellulose fibre has a degree of substitution of at least 0.05 carboxymethyl groups per glucose unit and a tenacity of at least 10 cN/tex.

13. The method as claimed in claim 3 , wherein the carboxymethylcellulose is suitable for use in the treatment of wounds.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Oct 25, 2019
From: WILMINGTON TRUST (LONDON) LIMITED
To: CONVATEC TECHNOLOGIES INC.
Reel/Frame 050831/0001 →
SECURITY AGREEMENT Recorded Nov 3, 2016
From: CONVATEC INC.; CONVATEC TECHNOLOGIES INC.; 180 MEDICAL, INC.; PRN MEDICAL SERVICES, LLC
To: WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL AGENT
Reel/Frame 040552/0227 →
RELEASE OF SECURITY INTEREST Recorded Nov 2, 2016
From: JPMORGAN CHASE BANK, N.A.
To: CONVATEC TECHNOLOGIES, INC.; CONVATEC LIMITED; UNOMEDICAL LIMITED; UNOMEDICAL A/S
Reel/Frame 040543/0357 →
SECURITY AGREEMENT Recorded Jan 6, 2011
From: CONVATEC TECHNOLOGIES, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 025591/0856 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2010
From: BRISTOL-MYERS SQUIBB COMPANY
To: CONVATEC INC.
Reel/Frame 024205/0064 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2010
From: CONVATEC INC.
To: CONVATEC TECHNOLOGIES INC.
Reel/Frame 024205/0110 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2010
From: ADAMS, SIMON; KERSHAW, DAVID
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 023824/0600 →
Priority Claims (1)
GB 0623473.6 · Nov 24, 2006 · national
Continuity (1)
Related Publication 20100144669A1 · Jun 10, 2010